- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Evan Morris, Roche
S
Evan Morris
VP, Government Affairs and Public Policy, Roche
SECRET TO SUCCESS: "It's what you know, not who you know"
SECRET: "I'm a crummy golfer"
After training at DC's policy-and-lobbying powerhouse Patton Boggs, self-described "food and drug lawyer" Evan Morris joined Roche—and the industry—in January 2005. Having watched his mom beat breast cancer, he was inspired to play on the pharma team. "That was before FDA became managed through Congress," he says by way of acknowledging his baptism by partisan fire. Morris has led Roche's Washington office in negotiating policy for flu preparedness, hep C access, and Medicare and Medicaid. The just-barely-thirtysomething Morris is already an old hand inside the beltway. A White House intern at 18, he learned a lasting lesson from his boss, the deputy chief of staff: "'Speak truth to power, no matter how powerful the individual or how ugly the truth.' At the end of the day, that's how I want to be known."
Evan Morris
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
